At a glance
ClinicalIndex Comparison Record- ✓Age 18 to 70 years
- ✓Lung cancer stages IB to IV
- ✓Received systemic oncological treatment for at least 3 months or in follow-up after ≥3 months treatment with stable/responding disease
- ✓ECOG performance status ≤2
- ✕Uncontrolled comorbidities (renal failure, cardiovascular disease, etc.)
- ✕Physical disability or cognitive impairment preventing completion of electronic data collection
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Characteristics of Sexual Dysfunction in Patients With Lung Cancer
In Brief
An observational study evaluating Systemic oncological treatment for Lung Cancer and Sexual Dysfunction. Completed, enrolled 553 participants across 29 sites in 5 countries.
Detailed Summary
The general objective of this observational study is identify and describe the type, frequency, and severity of sexual dysfunction in patients with lung cancer and generate strategies for clinical management and oncological follow-up directed and based on the specific findings in this population. The recruitment will be carried out from July 2023 and will be carried out until December 2023, the analysis of the information will be carried out from January to March 2024.
Study Details
Timeline
Interventions
Oncological systemic treatment for at least 3 months or being in oncological follow-up after having received systemic treatment for a minimum of 3 months